BJO

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Luu, C D
Right arrow Articles by Tan, D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luu, C D
Right arrow Articles by Tan, D
Topic Collections
Right arrowRelevant Article
British Journal of Ophthalmology 2005;89:151-153
© 2005 BMJ Publishing Group Ltd


SCIENTIFIC REPORT

Multifocal electroretinogram in children on atropine treatment for myopia

C D Luu1, A M I Lau1, A H C Koh, D Tan1,2

1 Singapore Eye Research Institute, Singapore
2 Singapore National Eye Centre, Singapore

Correspondence to:
Correspondence to:
Dr Chi D Luu
Singapore Eye Research Institute, 11 Third Hospital Avenue, Singapore 168751; seri_chiluu{at}snec.com.sg


ABSTRACT
Aim: To assess retinal function by multifocal electroretinogram (mfERG) in children on atropine eye drops for the treatment of myopia.

Methods: mfERGs were recorded in children receiving atropine eye drops (n = 48) once daily for 2 years and in those receiving placebo eye drops (n = 57) for a similar time. All recordings were performed between the second and third month of cessation of atropine/placebo treatment by a masked investigator. The amplitude and implicit time of the first order kernel (k1) and first slice of the second order kernel (k21) of mfERG responses were used to study the outer and inner retinal function, respectively.

Results: There was no significant reduction in k1 response amplitudes of the atropine group compared to that of the placebo group (N1, p = 0.181; P1, p = 0.150). No significant difference in the k1 response implicit times between the groups was found (N1, p = 0.767; P1, p = 0.849). The differences in the k21 amplitudes and implicit times between the groups were not statistically significant (k21 amplitude, p = 0.058; k21 implicit time, p = 0.156).

Conclusions: Daily atropine usage over 2 years for the treatment of myopia has no significant effect on retinal function as demonstrated by recordings of mfERG.


Abbreviations: ATOM study, Atropine in the Treatment of Myopia study; ISCEV, International Society for Clinical Electrophysiology of Vision; mfERG, multifocal electroretinogram

Keywords: retina; electroretinogram; multifocal electroretinogram; myopia; atropine


Relevant Article

BJO at a glance
Creig Hoyt
Br. J. Ophthalmol. 2005 89: 127. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
IOVSHome page
S. Liu, J. Li, D. T. H. Tan, and R. W. Beuerman
Expression and Function of Muscarinic Receptor Subtypes on Human Cornea and Conjunctiva
Invest. Ophthalmol. Vis. Sci., July 1, 2007; 48(7): 2987 - 2996.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 by the BMJ Publishing Group Ltd.